214 related articles for article (PubMed ID: 31798588)
1. Molecular Analysis of Goodpasture's Disease Following Hematopoietic Stem Cell Transplant in a Pediatric Patient, Recalls the Conformeropathy of Wild-Type Anti-GBM Disease.
Gray PE; McCarthy H; Siggs OM; Saleem MA; O' Brien T; Frith K; Ziegler JB; Kitching AR; Fogo AB; Hudson BG; Pedchenko V
Front Immunol; 2019; 10():2659. PubMed ID: 31798588
[No Abstract] [Full Text] [Related]
2. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to α5 chain of collagen IV are pathogenic in Goodpasture's disease.
Cui Z; Zhao MH; Jia XY; Wang M; Hu SY; Wang SX; Yu F; Brown KL; Hudson BG; Pedchenko V
J Autoimmun; 2016 Jun; 70():1-11. PubMed ID: 27117167
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
5. Quaternary epitopes of α345(IV) collagen initiate Alport post-transplant anti-GBM nephritis.
Olaru F; Luo W; Wang XP; Ge L; Hertz JM; Kashtan CE; Sado Y; Segal Y; Hudson BG; Borza DB
J Am Soc Nephrol; 2013 May; 24(6):889-95. PubMed ID: 23620401
[TBL] [Abstract][Full Text] [Related]
6. Autoepitopes and alloepitopes of type IV collagen: role in the molecular pathogenesis of anti-GBM antibody glomerulonephritis.
Borza DB
Nephron Exp Nephrol; 2007; 106(2):e37-43. PubMed ID: 17570938
[TBL] [Abstract][Full Text] [Related]
7. Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for α345NC1 hexamers.
Olaru F; Wang XP; Luo W; Ge L; Miner JH; Kleinau S; Geiger XJ; Wasiluk A; Heidet L; Kitching AR; Borza DB
J Immunol; 2013 Feb; 190(4):1424-32. PubMed ID: 23303673
[TBL] [Abstract][Full Text] [Related]
8. Goodpasture's disease: a report of ten cases and a review of the literature.
Dammacco F; Battaglia S; Gesualdo L; Racanelli V
Autoimmun Rev; 2013 Sep; 12(11):1101-8. PubMed ID: 23806563
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge issues in Goodpasture's disease.
Chan AL; Louie S; Leslie KO; Juarez MM; Albertson TE
Clin Rev Allergy Immunol; 2011 Oct; 41(2):151-62. PubMed ID: 21207195
[TBL] [Abstract][Full Text] [Related]
10. Goodpasture's disease: molecular architecture of the autoantigen provides clues to etiology and pathogenesis.
Pedchenko V; Vanacore R; Hudson B
Curr Opin Nephrol Hypertens; 2011 May; 20(3):290-6. PubMed ID: 21378566
[TBL] [Abstract][Full Text] [Related]
11. Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease.
Yang R; Cui Z; Hellmark T; Segelmark M; Zhao MH; Wang HY
Clin Immunol; 2007 Aug; 124(2):207-12. PubMed ID: 17556023
[TBL] [Abstract][Full Text] [Related]
12. Analysis of T cell responses to the autoantigen in Goodpasture's disease.
Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD
Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665
[TBL] [Abstract][Full Text] [Related]
13. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells.
Ooi JD; Holdsworth SR; Kitching AR
J Autoimmun; 2008 Nov; 31(3):295-300. PubMed ID: 18502098
[TBL] [Abstract][Full Text] [Related]
14. The goodpasture autoantigen. Identification of multiple cryptic epitopes on the NC1 domain of the alpha3(IV) collagen chain.
Borza DB; Netzer KO; Leinonen A; Todd P; Cervera J; Saus J; Hudson BG
J Biol Chem; 2000 Feb; 275(8):6030-7. PubMed ID: 10681598
[TBL] [Abstract][Full Text] [Related]
15. Characterization of autoantibodies from patients with Goodpasture's disease using a resonant mirror biosensor.
Dougan T; Levy JB; Salama A; George AJ; Pusey CD
Clin Exp Immunol; 2002 Jun; 128(3):555-61. PubMed ID: 12067312
[TBL] [Abstract][Full Text] [Related]
16. Epitope recognized by anti-glomerular basement membrane (GBM) antibody in a patient with repeated relapse of anti-GBM disease.
Nishibata Y; Masuda S; Nakazawa D; Tanaka S; Tomaru U; Nergui M; Jia X; Cui Z; Zhao MH; Nakabayashi K; Ishizu A
Exp Mol Pathol; 2019 Apr; 107():165-170. PubMed ID: 30817909
[TBL] [Abstract][Full Text] [Related]
17. The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.
Ooi JD; Chang J; O'Sullivan KM; Pedchenko V; Hudson BG; Vandenbark AA; Fugger L; Holdsworth SR; Kitching AR
J Am Soc Nephrol; 2013 Feb; 24(3):419-31. PubMed ID: 23411782
[TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides of Goodpasture's antigen in antiglomerular basement membrane nephritis in rats.
Luo AM; Fox JW; Chen L; Bolton WK
J Lab Clin Med; 2002 May; 139(5):303-10. PubMed ID: 12032491
[TBL] [Abstract][Full Text] [Related]
19. Recombinant alpha-chains of type IV collagen demonstrate that the amino terminal of the Goodpasture autoantigen is crucial for antibody recognition.
Ryan JJ; Mason PJ; Pusey CD; Turner N
Clin Exp Immunol; 1998 Jul; 113(1):17-27. PubMed ID: 9697978
[TBL] [Abstract][Full Text] [Related]
20. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
